An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer.
BACKGROUND:Standardly collected clinical and pathological patient information has demonstrated only moderate ability to predict risk of biochemical recurrence (BCR) of prostate cancer in men undergoing salvage radiation therapy (SRT) for a rising PSA after radical prostatectomy (RP). Although elevat...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4795739?pdf=render |
id |
doaj-600c5063e5e54eafbbc26a54ce9c5c55 |
---|---|
record_format |
Article |
spelling |
doaj-600c5063e5e54eafbbc26a54ce9c5c552020-11-25T01:25:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01113e015178510.1371/journal.pone.0151785An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer.Michael G HeckmanJessica L RobinsonKatherine S TzouAlexander S ParkerKevin J WuTracy W HiltonWilliam J HowatJodi L MillerPamela A KreinestThomas M PisanskySteven E SchildJennifer L PetersonLaura A VallowJason S CarrollSteven J BuskirkBACKGROUND:Standardly collected clinical and pathological patient information has demonstrated only moderate ability to predict risk of biochemical recurrence (BCR) of prostate cancer in men undergoing salvage radiation therapy (SRT) for a rising PSA after radical prostatectomy (RP). Although elevated FOXA1 staining has been associated with poor patient outcomes following RP, it has not been studied in the specific setting of SRT after RP. The aim of this study was to evaluate the association between FOXA1 staining level and BCR after SRT for recurrent prostate cancer. METHODS:A total of 141 men who underwent SRT at our institution were included. FOXA1 staining levels in primary tumor samples were detected using immunohistochemistry. FOXA1 staining percentage and intensity were measured and multiplied together to obtain a FOXA1 H-score (range 0-12) which was our primary staining measure. P-values ≤ 0.0056 were considered as statistically significant after applying a Bonferroni correction for multiple comparisons. RESULTS:There was not a significant association between FOXA1 H-score and risk of BCR when considering H-score as an ordinal variable or as a categorical variable (all P ≥ 0.090). Similarly, no significant associations with BCR were observed for FOXA1 staining percentage or staining intensity (all P ≥ 0.14). CONCLUSIONS:FOXA1 staining level does not appear to have a major impact on risk of BCR after SRT.http://europepmc.org/articles/PMC4795739?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Michael G Heckman Jessica L Robinson Katherine S Tzou Alexander S Parker Kevin J Wu Tracy W Hilton William J Howat Jodi L Miller Pamela A Kreinest Thomas M Pisansky Steven E Schild Jennifer L Peterson Laura A Vallow Jason S Carroll Steven J Buskirk |
spellingShingle |
Michael G Heckman Jessica L Robinson Katherine S Tzou Alexander S Parker Kevin J Wu Tracy W Hilton William J Howat Jodi L Miller Pamela A Kreinest Thomas M Pisansky Steven E Schild Jennifer L Peterson Laura A Vallow Jason S Carroll Steven J Buskirk An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer. PLoS ONE |
author_facet |
Michael G Heckman Jessica L Robinson Katherine S Tzou Alexander S Parker Kevin J Wu Tracy W Hilton William J Howat Jodi L Miller Pamela A Kreinest Thomas M Pisansky Steven E Schild Jennifer L Peterson Laura A Vallow Jason S Carroll Steven J Buskirk |
author_sort |
Michael G Heckman |
title |
An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer. |
title_short |
An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer. |
title_full |
An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer. |
title_fullStr |
An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer. |
title_full_unstemmed |
An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer. |
title_sort |
examination of the association between foxa1 staining level and biochemical recurrence following salvage radiation therapy for recurrent prostate cancer. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2016-01-01 |
description |
BACKGROUND:Standardly collected clinical and pathological patient information has demonstrated only moderate ability to predict risk of biochemical recurrence (BCR) of prostate cancer in men undergoing salvage radiation therapy (SRT) for a rising PSA after radical prostatectomy (RP). Although elevated FOXA1 staining has been associated with poor patient outcomes following RP, it has not been studied in the specific setting of SRT after RP. The aim of this study was to evaluate the association between FOXA1 staining level and BCR after SRT for recurrent prostate cancer. METHODS:A total of 141 men who underwent SRT at our institution were included. FOXA1 staining levels in primary tumor samples were detected using immunohistochemistry. FOXA1 staining percentage and intensity were measured and multiplied together to obtain a FOXA1 H-score (range 0-12) which was our primary staining measure. P-values ≤ 0.0056 were considered as statistically significant after applying a Bonferroni correction for multiple comparisons. RESULTS:There was not a significant association between FOXA1 H-score and risk of BCR when considering H-score as an ordinal variable or as a categorical variable (all P ≥ 0.090). Similarly, no significant associations with BCR were observed for FOXA1 staining percentage or staining intensity (all P ≥ 0.14). CONCLUSIONS:FOXA1 staining level does not appear to have a major impact on risk of BCR after SRT. |
url |
http://europepmc.org/articles/PMC4795739?pdf=render |
work_keys_str_mv |
AT michaelgheckman anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT jessicalrobinson anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT katherinestzou anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT alexandersparker anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT kevinjwu anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT tracywhilton anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT williamjhowat anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT jodilmiller anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT pamelaakreinest anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT thomasmpisansky anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT steveneschild anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT jenniferlpeterson anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT lauraavallow anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT jasonscarroll anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT stevenjbuskirk anexaminationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT michaelgheckman examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT jessicalrobinson examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT katherinestzou examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT alexandersparker examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT kevinjwu examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT tracywhilton examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT williamjhowat examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT jodilmiller examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT pamelaakreinest examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT thomasmpisansky examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT steveneschild examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT jenniferlpeterson examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT lauraavallow examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT jasonscarroll examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer AT stevenjbuskirk examinationoftheassociationbetweenfoxa1staininglevelandbiochemicalrecurrencefollowingsalvageradiationtherapyforrecurrentprostatecancer |
_version_ |
1725114841592496128 |